| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 07/19/2001 | WO2000078814A3 LO-CD2b ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 07/19/2001 | WO2000078813A3 Huntington disease cellular model: stably transfected pc12 cells expressing mutant huntingtin |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | WO2000069891A3 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/19/2001 | WO2000044782A3 Ewing's tumour antigen, nucleic acid and antibodies |
| 07/19/2001 | WO2000041474A3 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/19/2001 | WO2000025808A9 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 07/19/2001 | WO2000023573A9 Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies |
| 07/19/2001 | US20010008934 Stablity; useful in drugs, vaccines, personal care/cosmetics, veterinary drugs/vaccines, foods, feeds, diagnostics, cleaning agents (detergents and decontaminants); catalytic and binding components of biosensors |
| 07/19/2001 | US20010008767 Isolation of antibody; binding |
| 07/19/2001 | US20010008764 Heparin binding protein |
| 07/19/2001 | US20010008759 Contacting target cells with member of antibody phage display library |
| 07/19/2001 | US20010008625 Receptor binding conjugates |
| 07/19/2001 | DE10002895A1 Co-immobilization of species on a carrier surface, useful e.g. for purification or as a sensor, comprises surface passivated to prevent non-specific adsorption |
| 07/19/2001 | DE10000440A1 Monoclonal antibody for the determination of nitrite reductase |
| 07/19/2001 | CA2406722A1 Dna modification proteins |
| 07/19/2001 | CA2397741A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397334A1 Secreted proteins |
| 07/19/2001 | CA2397207A1 Novel stra6 polypeptides |
| 07/19/2001 | CA2397199A1 Nogo receptor-mediated blockade of axonal growth |
| 07/19/2001 | CA2397162A1 Circularly permutated, interaction-activated proteins |
| 07/19/2001 | CA2397053A1 Human and parasite orphan receptor proteins |
| 07/19/2001 | CA2396889A1 Novel peptide and screening method by using the same |
| 07/19/2001 | CA2396235A1 Anti-angiogenic proteins and fragments and methods of use thereof |
| 07/19/2001 | CA2395700A1 Antibodies specific for proteins having polyglutamine expansions |
| 07/18/2001 | EP1116792A1 New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 07/18/2001 | EP1116031A1 DIAGNOSTIC ASSAYS FOR DETECTION OF $i(ENTAMOEBA HISTOLYTICA) |
| 07/18/2001 | EP1116029A1 Apoptosis marker antibodies and methods of use |
| 07/18/2001 | EP1116028A1 Ndp |
| 07/18/2001 | EP1115875A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae |
| 07/18/2001 | EP1115874A2 Alzheimer's disease secretase |
| 07/18/2001 | EP1115867A1 Human interleukin-b50. therapeutic uses |
| 07/18/2001 | EP1115865A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 07/18/2001 | EP1115863A1 Ucp4 |
| 07/18/2001 | EP1115862A2 Cytokine receptor zalpha11 |
| 07/18/2001 | EP1115860A2 Membrane-associated organizational proteins |
| 07/18/2001 | EP1115847A1 Short peptides which selectively modulate the activity of protein kinases |
| 07/18/2001 | EP1115746A2 Antibodies to mammalian langerhans cell antigen and their uses |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115427A1 Time-staggered utilization of tumor cells in combination with intact antibodies for immunization |
| 07/18/2001 | EP1115426A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 07/18/2001 | EP1115425A1 Autoantibody inhibitors |
| 07/18/2001 | EP1115418A2 Aglyco products and methods of use |
| 07/18/2001 | EP1115405A1 Use of certain drugs for treating nerve root injury |
| 07/18/2001 | EP0752869B1 Cells with multiple altered epitopes on a surface antigen for use in transplantation |
| 07/18/2001 | EP0742830B1 Fusion proteins that include antibody and nonantibody portions |
| 07/18/2001 | EP0639083B1 Complexing agents and targeting immunoreagents |
| 07/18/2001 | EP0575555B1 Protein-induced morphogenesis |
| 07/18/2001 | CN1304454A Novel nucleic acids and polypeptides related to farnesyl-directed endopeptidase |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304448A Groups for genes expressed in human dendritic cells |
| 07/18/2001 | CN1303943A Novel polypeptide-CoA carboxylase 41 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303941A Human charcot-leyden crystal 3, its code sequence, preparation method and application |
| 07/18/2001 | CN1303940A Human charcot-leyden crystal 2, its code sequence and preparation method and application |
| 07/18/2001 | CN1303939A Novel polypeptide-transcription factor 43 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303938A Novel polypeptide-human MATH37 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303937A Novel polypeptide-human tissue anion transport polypeptide 41 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303935A Human charcot-leyden crystal 6, its code sequence, preparation method and application |
| 07/18/2001 | CN1303934A Novel polypeptide-human Ra1BPI related protein 82 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303933A Novel polypeptide-human muscle BOP protein 41 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303932A Novel polypeptide-neurogenesis related protein 18 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303929A Novel polypeptide-robosomal protein 18 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303926A Novel polypeptide-NADH-cytochrome B5 reductase 33 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303869A Egg yellow antiinterleukin -8 antibody, preparation method and its application |
| 07/18/2001 | CN1303863A Novel polypeptide-human transcriptional elongation factor IIS51 and polynucleotide for coding this polypeptide |
| 07/18/2001 | CN1303861A Novel retinoblastoma protein binding protein, its preparation and application |
| 07/18/2001 | CN1068524C Medicine for curing intractable psoriasis |
| 07/17/2001 | USRE37286 Method of cleansing a protein from multivalent metal ions bound thereto |
| 07/17/2001 | US6262333 Human genes and gene expression products |
| 07/17/2001 | US6262257 Selective ion- and neutral molecule-binding agents forming supramolecular ensembles, and ion- and neutral molecule-separation agents |
| 07/17/2001 | US6262248 Dna encoding an arabidopsis thaliana rps2 polypeptide in plant cells provides resistance to pathogens |
| 07/17/2001 | US6262246 DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof |
| 07/17/2001 | US6262244 Genes coding for the extracellular part of four specific nkg2 (natural killer) transmembrane proteins; useful in treating infectious diseases and cancer |
| 07/17/2001 | US6262242 Tumor suppressor designated TS10Q23.3 |
| 07/17/2001 | US6262239 TNF receptor-specific antibodies |
| 07/17/2001 | US6262237 Contacting protocadherin-encoding polynucleotide sequence with antibody (monoclonal, polyclonal, chimeric or humanized) antagonizes homophilic binding; useful for intercellular adhesion |
| 07/17/2001 | US6262236 Fibrin sealant compositions and methods for utilizing same |
| 07/17/2001 | US6262079 Prevention and treatment of cardiovascular pathologies |
| 07/17/2001 | US6262025 Their encoded protein products, as well as derivatives and analogs thereof. |
| 07/17/2001 | US6262024 Neuron regulatory factor for promoting neuron survival |
| 07/17/2001 | US6262016 Transferrin receptor genes |
| 07/17/2001 | US6261820 Fibronolytically active polypeptide |
| 07/17/2001 | US6261818 Nucleotide sequence of cardiac-related ankyrin-repeat protein kinase; antisense agents; probes; primers; vectors; host cells; antibodies; diagnosis and treatment of cardiovascular disorders |
| 07/17/2001 | US6261817 Guaa |
| 07/17/2001 | US6261803 Process for preparing functional recombinant tissue factor |
| 07/17/2001 | US6261802 Ups (ugc) |
| 07/17/2001 | US6261801 Nucleic acids encoding tumor necrosis factor receptor 5 |
| 07/17/2001 | US6261800 Luteinizing hormone/choriogonadotropin (LH/CG) receptor |
| 07/17/2001 | US6261791 Method for diagnosing cancer using specific PSCA antibodies |
| 07/17/2001 | US6261790 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 07/17/2001 | US6261789 Detecting prostate stem cell antigen proteins by contacting sample with monoclonal antibody in an immunoassay |
| 07/17/2001 | US6261787 Bifunctional molecules for delivery of therapeutics |
| 07/17/2001 | US6261778 Isolated nucleic acid molecules which encode SCP proteins, and uses thereof |
| 07/17/2001 | US6261776 Nucleic acid arrays |
| 07/17/2001 | US6261763 Fluorescence resonance energy transfer screening assay for the identification of compounds that are capable of abrogating macrophage-tropic HIV-1 cell fusion |
| 07/17/2001 | US6261571 Immunogenic compositions comprising dimeric forms of the human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus (SIV) envelope glycoproteins |
| 07/17/2001 | US6261569 Antigens; mixed with carriers; genetic engineering |